EMA/PE/0000182225 - paediatric investigation plan

eneboparatide

Key facts

• Active substance:
  eneboparatide
• Therapeutic area:
  Endocrine disorders
• Decision number:
  EMA/PE/0000182225
• PIP number:
  EMA/PE/0000182225
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of hypoparathyroidism
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  16/04/2025
• Compliance check done:
  No

Decision

EMA/PE/0000182225 : EMA decision of 16 April 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral for eneboparatide

Adopted Reference Number: EMADOC-1700519818-2036752